Literature DB >> 4843571

Sodium cyanate induced polyneuropathy in patients with sickle-cell disease.

C M Peterson, P Tsairis, A Onishi, Y S Lu, R Grady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4843571     DOI： 10.7326/0003-4819-81-2-152

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea.

Authors:  Cristiane O Renó; Amanda Rodrigues Barbosa; Sara Santos de Carvalho; Melina B Pinheiro; Danyelle Romana Rios; Vanessa F Cortes; Leandro A Barbosa; Hérica L Santos
Journal:  Ann Hematol       Date:  2020-03-12       Impact factor: 3.673

2.  Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.

Authors:  D A Deiderich; R C Trueworthy; P Gill; A M Cader; W E Larsen
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

3.  Neurotoxicity of sodium cyanate. New pathological and ultrastructural observations in Maccaca nemestrina.

Authors:  I Tellez; D Johnson; R L Nagel; A Cerami
Journal:  Acta Neuropathol       Date:  1979-06-15       Impact factor: 17.088

4.  Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.

Authors:  Michael Ziegelasch; Myrthe A M van Delft; Philip Wallin; Thomas Skogh; César Magro-Checa; Gerda M Steup-Beekman; Leendert A Trouw; Alf Kastbom; Christopher Sjöwall
Journal:  Arthritis Res Ther       Date:  2016-12-03       Impact factor: 5.156

5.  Peripheral nerve pathology in sickle cell disease mice.

Authors:  Katelyn E Sadler; Tylor R Lewis; Tyler B Waltz; Joseph C Besharse; Cheryl L Stucky
Journal:  Pain Rep       Date:  2019-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.